ew
Insights of Biomedical Research
Open Access | Page 52 |
Vol 3 | Issue 1 | Pages 52-55
Copyright: © 2019 Tsompos C, et al. This is an open-access arcle distributed under the terms
of the Creave Commons Aribuon License, which permits unrestricted use, distribuon, and
reproducon in any medium, provided the original author and source are credited.
ISSN: 2642-4576
*Corresponding author: Constannos Tsompos, Department of
Gynecology, General Hospital of Thessaloniki “St. Dimitrios” 2
Elenis Zografou Street, Thessaloniki 54634, Hellas, Greece, Tel:
00302313322171; 00306946674264, Fax: 00302106811215
Accepted: August 08, 2019
Published online: August 10, 2019
Citaon: Tsompos C, Panoulis C, Toutouzas K, et al. (2019)
Comparison of the Hyponatremic Effects of Erythropoien and
U-74389G. Insights Biomed Res 3(1):52-55
SCHOLARS. DIRECT
DOI: 10.36959/584/446
Comparison of the Hyponatremic Effects of Erythropoietin and
U-74389G
Constannos Tsompos
1*
, Constannos Panoulis
2
, Konstannos Toutouzas
3
, Aggeliki Triantafyllou
4
,
George C Zografos
3
, Kalliopi Tsarea
5
, Maria Karamperi
5
and Apostolos Papalois
6
1
Department of Gynecology, General Hospital of Thessaloniki “St. Dimitrios” Thessaloniki, Greece
2
Department of Obstetrics & Gynecology, Aretaieion Hospital, Athens University, Greece
3
Department of Surgery, Ippokrateion General Hospital, Athens University, Greece
4
Department of Biologic Chemistry, Athens University, Greece
5
Experimental Research Centre ELPEN Pharmaceucals, S.A. Inc., Co., Greece
6
Experimental, Educaonal and Research Center ELPEN, School of Medicine, European University Cyprus, Greece
Introduction
The lazaroid U-74389G (L) may be not famous for its
hyponatremic [1] capacity (p-value = 0.3693). U-74389G as
a novel anoxidant factor, implicates exactly only 260 pub-
lished studies. The ischemia reperfusion (IR) type of experi-
ments was noted in 18.84% of these studies. A ssue protec-
ve feature of U-74389G was obvious in these IR studies. The
U-74389G chemically known as 21-[4-(2,6-di-1-pyrrolidinyl-4-
pyrimidinyl)-1-piperazinyl]-pregna-1,4,9(11)-triene-3,20-di-
one male ate salt is an anoxidant complex, which prevents
the lipid peroxidaon either iron-dependent, or arachidonic
acid-induced one. Animal kidney, liver, brain microvascular
endothelial cells monolayers and heart models were protect-
ed by U-74389G aſter IR injury. U-74389G also aenuates the
leukocytes; down-regulates the proinflammatory gene; treats
Research Article
Abstract
Aim: This study calculated the effects on serum sodium (Na) levels, aſter treatment with either of 2 drugs: The
erythropoien (Epo) and the anoxidant lazaroid (L) drug U-74389G. The calculaon was based on the results of 2
preliminary studies, each one of which esmated the certain influence, aſter the respecve drug usage in an induced
ischemia reperfusion (IR) animal experiment.
Materials and methods: The 2 main experimental endpoints at which the serum Na levels were evaluated was the 60
th
reperfusion min (for the groups A, C and E) and the 120
th
reperfusion min (for the groups B, D and F). Specially, the groups
A and B were processed without drugs, groups C and D aſter Epo administraon; whereas groups E and F aſter the L
administraon.
Results: The first preliminary study of Epo presented a non significant hyponatremic effect by 0.11% ± 0.38% (p-value =
0.7531). The second preliminary study of U-74389G presented a non significant hyponatremic effect by 0.32% ± 0.36%
(p-value = 0.3693). These 2 studies were co-evaluated since they came from the same experimental seng. The outcome
of the co-evaluaon was that L is 2.74914-fold [2.74424-2.754048] more hyponatremic than Epo (p-value = 0.0000).
Conclusions: The an-oxidant capacies of U-74389G ascribe 2.74914-fold more hyponatremic effects than Epo (p-value
= 0.0000).
Keywords
Ischemia, Erythropoien, U-74389G, Serum sodium levels, Reperfusion
the endotoxin shock; produces cytokine; enhances the mono-
nuclear immunity; protects the endothelium and presents
anshock property.
Erythropoien (Epo) even if is not famous for its hypona-